CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 9/10, October/November 2013
368
AFRICA
ulnar artery and brachiocephalic vein with saphenous vein graft
ınterposition: a renal hemodialysis dependent patient.
Turkish J Vasc
Surg
2007;
16
(3): 49–54.
17. Dilege S, Baktiroglu S, Basar Y, Genc FA, Ozgür M. Basilic vein
transposition as vascular access for hemodialysis
. GKD Cer Derg
1995;
3
: 140–142.
18. Veeramani M, Vyas J, Sabnis R, Desai M. Small incision basilic vein
transposition technique: A good alternative to standard method.
Indian
J Urol
2010;
26
: 145–147.
19. Rivers SP, Scher LA, Sheehan E, Lynn R, Veith FJ. Basilic vein trans-
position: an underused autologous alternative to prosthetic dialysis
angioaccess.
J Vasc Surg
1993;
18
: 391–397.
20. Davoudi M, Tayebi P, Baheshtian A. Primary patency time of basilic
vein transposition versus prosthetic brachioaxillary access grafts
in hemodialysis patients.
J Vasc Access
2012; e-publ. Doi:10.5301/
jva.5000109.
21. Woo K, Farber A, Doros G, Killeen K, Kohanzadeh S. Evaluation of
the efficacy of the transposed upper arm arteriovenous fistula: a single
institutional review of 190 basilic and cephalic vein transposition proce-
dures.
J Vasc Surg
2007;
46
: 94–100.
22. Harper SJF, Goncalves I, Doughman T, Nicholson ML. Arteriovenous
fistula formation using transposed basilic vein: extensive single centre
experience
. Eur J Vasc Endovasc Surg
2008;
36
: 237–241.
23. Ascher E, Hingoran A, Gunduz Y, Yorkovich Y, Ward M, Miranda J,
et
al
. The value and limitations of the arm cephalic and basilic vein for
arteriovenous access.
Ann Vasc Surg
2001;
15
: 89–97.
24. Wolford HY, Hsu J, Rhodes JM, Shortell CK, Davies MG, Bakhru A,
et
al
. Outcome after autogenous brachial-basilic upper arm transpositions
in the post-National Kidney Foundation Dialysis Outcomes Quality
Initiative era.
J Vasc Surg
2005;
42
: 951–956.
25. Butterworth PC, Doughman TM, Wheatley TJ, Nicholson ML.
Arteriovenous fistula using transposed basilic vein.
Br J Surg
1998;
85
: 653–654.
26. Choi HM, Lal BK, Cerveira JJ, Padberg FT Jr, Silva MB Jr, Hobson
RW 2nd,
et al.
Durability and cumulative functional patency of trans-
posed and nontransposed arteriovenous fistulas.
J Vasc Surg
2003;
38
:
1206–1212.
27. Murphy GJ, White SA, Knight AJ, Doughman T, Nicholson ML. Long-
term results of arteriovenous fistulas using transposed autologous
basilic vein.
Br J Surg
2000;
87
: 819–823.
28. Rao RK, Azin GD, Hood DB, Rowe VL, Kohl RD, Katz SG,
et al
.
Basilic vein transposition fistula: a good option for maintaining hemo-
dialysis access site options?
J Vasc Surg
2004;
39
: 1043–1047.
29. Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann
C. Outcomes of upper arm arteriovenous fistulas for maintenance
hemodialysis access.
Arch Surg
2004;
139
: 201–208.
30. Cantelmo NL, LoGerfo FW, Menzoian JO. Brachiobasilic and brachio-
cephalic fistulas as secondary angioaccess routes.
Surg Gynecol Obstet
1982;
155
: 545–548.
31. Kakkos SK, Haddad GK, Weaver MR, Haddad RK, Scully MM. Basilic
vein transposition: What is the optimal technique?
Eur J Vasc Endovasc
Surg
2010;
39
: 612–619.
32. Patel ST, Hughes J, Mills JL Sr. Failure of arteriovenous fistula matura-
tion: an unintended consequence of exceeding dialysis outcome quality
initiative guidelines for hemodialysis Access.
J Vasc Surg
2003;
38
(3):
439–445.
33. Berman SS, Gentile AT. Impact of secondary procedures in autogenous
arteriovenous fistula maturation and maintenance.
J Vasc Surg
2001;
34
: 866–871.
34. Sunil S, Sinha S, Sharma AK. Provision of long-term vascular access
for haemodialysis in a patient with exhausted superficial arm veins.
Br
J Surg
2002;
89
: 122–123.
… continued from page 363
Medicine at the University of Cape Town.
He is also adjunct associate professor in
the Department of Epidemiology, Mailman
School of Public Health, Columbia University,
New York, USA. His specific research
focus is on reducing the impact of HIV/
AIDS on women’s, maternal and child health,
particularly in the areas of prevention of
mother-to-child HIV transmission and
contraception for HIV-infected women.
He has published more than 150 peer-
reviewed scientific publications and also serves
on a number of national and international
scientific committees. He has been an active
proponent of open-access scientific publishing
as part of a broader commitment to increasing
the availability and uptake of research across
Africa. Linked to this, he is the editor of
the
South African Journal of HIV Medicine
and helped move the journal to an open-
access platform with international indexing.
His research has been recognised through
a number of prestigious awards, including
the British Association Award (silver medal)
from the Southern African Association for
the Advancement of Science (2012) and the
International Leadership Award from the
Elizabeth Glaser Paediatric AIDS Foundation
(2011–2014).
Scheffer is the founder of the Biomedical
Engineering Research Group (BERG) at
Stellenbosch University. BERG is currently
one of the leading groups in South Africa for
research in the field of biomedical engineering.
He has co-authored more than 100 scientific
articles and supervised a vast number of
postgraduate students. Some of his previous
prizes and awards include, ‘Upcoming
researcher of the year’, Faculty of Engineering,
University of Stellenbosch, 2005; Winner in
the DTI Technology Awards 2008 for best
SMME development; Joint winner of the
Baumgarten-Wagon award (Germany) in 2009
for outstanding contributions to engineering
education, and the Rector’s award for excellent
research 2010 and 2012.
At the same event, the Sydney Brenner
Fellowship, administered by the Academy
and supported by the Oppenheimer Memorial
Trust, was awarded for postdoctoral studies
in the molecular and cellular biosciences
conducted at an advanced level in South
Africa. This award was established when Dr
Sydney Brenner donated a portion of his 2002
Nobel Prize to ASSAf to permit ASSAf (in
partnership with the Oppenheimer Memorial
Trust) to offer a prestigious postdoctoral
Fellowship for research in molecular biology
to be undertaken in South Africa over two
years by an outstanding young scientist.
The emphasis in the selection is on the
excellence of the academic track record,
evidence of unusual creativity and ingenuity
in addressing scientific problems, both
the novelty and feasibility of the proposed
approach, and the quality, adequacy and
appropriateness of the host environment.
The 2014/15 Fellowship was awarded to
Dr Anna Coussens, a postdoctoral research
fellow at the University of Cape Town.
She received her PhD from Queensland
University of Technology, Australia, in
developmental molecular biology. Thereafter
she volunteered in Uganda with a medical
students’ organisation, running health surveys
in remote communities. This experience
shaped her desire to become an infectious
disease immunologist. She then moved to
London where she contributed significantly to
a programme of work on vitamin D regulation
of the immune response to tuberculosis. Now
in Cape Town, she is defining how seasonal
UVB patterns affect vitamin D levels in
healthy young adults and how this impacts
on their immune response to HIV-1 infection.
